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Is what’s good for the gander good for the goose?
Nanette K. Wenger, MD
Editorial Note: The gender ini-
tiative, a provocative series on
gender differences in the surgi-
cal treatment of cardiac, vascu-
lar, and thoracic disease, con-
tinues this month with editorials
on coronary revascularization in
women.
A foremost expert in gender-spe-
cific risks and outcomes, Nanette
K. Wenger, MD, summarizes the
best available data, progress to
date, and remaining questions for
women undergoing coronary re-
vascularization. Another group
summarizes the statistical prob-
lems that may confound studies
of gender differences. Finally,
cardiac surgeons contemplate
possible differences in the tech-
nical aspects of coronary artery
bypass grafting. The series con-
tinues in December with editori-
als on coronary artery surgery
and recovery.
Nancy A. Nussmeier, MD
Texas Heart Institute
See related editorials on pages
932, 936, 950, and 959.
Coronary heart disease is the leading cause of death for women in theUnited States, accounting for almost 250,000 deaths annually.Since 1984 more US women than men have died each year ofcardiovascular disease. Emerging data have reinforced sex-relateddifferences in responses to therapies, including adverse responses.This editorial highlights the excess mortality of coronary artery
bypass graft (CABG) surgery in women, addressing the need to derive more detailed
sex-specific information that has the potential to improve clinical outcomes. Owing
to the paucity of randomized trial data for women, the material presented derives
primarily from databases, registries, and case series.
What We Know
Rates of performance of CABG surgery in the Coronary Artery Surgery Study
(CASS) Registry, when adjusted for clinical and angiographic characteristics, were
comparable for women and men. There were few sex differences in long-term
survival, differing only by the variance in operative mortality, 5.3% for women
versus 2.5% for men.1 Details of the operative mortality characteristics are not
presented. Can they be derived from this data set? If not, would systematic medical
record review of fatalities be feasible? As in other settings, conventional coronary
risk reduction was likely suboptimal,2 a problem also common to men after CABG
surgery until very recent years.
The Society of Thoracic Surgeons National Cardiac Surgery Database, which
retrospectively examined 334,913 patients undergoing CABG surgery since 1994,
provided important sex-based data.3 Women, who constituted 28% of the reported
population, had an operative mortality of 4.5% compared with 2.6% for men (P 
.0001). Although the mortality rate remained significantly higher for women for
each of the multiple risk factors examined univariately, multivariate analysis
showed that women continued to have higher mortality than equally matched men
in the low and medium risk spectrum. Only among very high risk patients was there
a sex-neutral mortality risk; patients at highest risk were elderly individuals, those
undergoing reoperation, and those having nonelective procedures. Greater mortality
risk for women persisted even after consideration of body surface area (a surrogate
for coronary artery size) and the use of internal thoracic artery grafting. Despite
comments that both immediate postoperative mortality and morbidity are higher in
women and that long-term survival is lower, specifics of the operative mortality are
not offered. It is this examination of situation- and cause-specific mortality that
might more precisely identify remediable problems.
By contrast, a report from the Bypass Angioplasty Revascularization Investiga-
tion (BARI) 4 showed comparable unadjusted 5-year mortality rates for women and
men; with correction for the higher risk profiles of women, female sex was described
as an independent predictor of improved 5-year survival. This does not, however,
warrant interpretation that women do better, only that sex per se is not the feature
responsible for increased mortality. BARI represents a small subset of CABG
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patients, specifically those eligible for either percutaneous
transluminal coronary angioplasty (PTCA) or CABG revas-
cularization. Nonetheless, BARI women, despite better left
ventricular systolic function, had an excess of periproce-
dural congestive heart failure or pulmonary edema, with
heart failure independently predicting mortality for both
women and men. Two issues must be raised: Does the
hypertrophied ventricle with diastolic dysfunction tolerate
poorly either transient myocardial ischemia or the volume
shifts of CABG surgery? Do the extent and pattern of left
ventricular hypertrophy differ by sex? Did more optimal
myocardial protection in BARI improve the outcome for
women undergoing CABG surgery and what were the char-
acteristics of this protection? Further, since preoperative
symptoms of unstable angina and severity of stable angina
were greater in women despite less angiographically severe
coronary disease, is there a pathophysiologic difference in
plaque rupture and/or endothelial dysfunction between
women and men—and does this affect perioperative out-
comes? In women with fatal coronary thrombosis in another
study, plaque characteristics differed between younger and
older women. Although, in the overall BARI cohort, CABG
offered an advantage compared with PTCA for diabetic
patients, the small numbers of women do not allow mean-
ingful comparisons specifically for women. The challenge
to the contemporary application of these data involves both
the change in percutaneous intervention procedures (includ-
ing stents and drug-eluting stents) and the change in CABG
surgery, with more frequent off-pump procedures, as well as
the more aggressive current coronary risk reduction inter-
ventions, in part enabled by newer medications.
The Northern New England Cardiovascular Disease
Study Group5 examined changes in hospital mortality over
time for women undergoing CABG surgery, 1987 to 1997.
Although in the recent years women were older, had poorer
ventricular function, and more often required urgent or
emergency CABG surgery, their mortality rates decreased
significantly; the absolute magnitude of the change in ad-
justed mortality rates over time was greater for women than
men (3.1% vs 1.5%). Among these almost 30,000 patients,
although women represented only 28% of the study popu-
lation, the decrease in mortality accounted for 44% of the
total decrease in adjusted mortality during the decade. Why
did these older and sicker women do better? Internal tho-
racic artery grafting increased, but off-pump CABG tech-
nique was not used significantly until the end of the study.
Did changes in surgical technique improve the approach to
smaller coronary vessels in women? Was myocardial pro-
tection better? What about approaches to hemodilutional
anemia and preinduction high heart rates, which predomi-
nated in women? Was there more precise attention to con-
comitant diabetes, to hypertension? Again, the details of the
CABG surgery mortality are not specified. Were deaths
operative, perioperative, or late during the hospital stay?
What were the specific mechanisms of death?
More women than men presenting for CABG surgery
have diabetes. The comparison of diabetic and nondiabetic
patients undergoing isolated CABG surgery (1995-1999)
showed longer intensive care and hospital stays; greater
need for inotropic agents, hemotransfusion, and dialysis;
and more frequent renal failure, stroke, mediastinitis, and
wound infection.6 Patients with insulin-dependent diabetes
had even less favorable outcomes. Unfortunately, the report
fails to provide sex-specific data. Important questions raised
include the role of more intensive insulin treatment and
strict blood glucose control.
Information from the National Cardiovascular Network
database (1993-1999) was derived from 51,187 patients,
30% women, who received CABG surgery. Women had
higher hospital mortality rates than men, and younger
women were at higher risk of hospital death than compara-
bly aged men.7 Women younger than age 50 years were 3
times more likely to die than their male counterparts.
Women had a greater occurrence of complications, but in
particular, renal failure, neurologic complications, and acute
myocardial infarction were more marked at younger ages.
Again, these younger women not only had more prevalent
risk factors but also had more prevalent diabetes. Mecha-
nisms for this excess mortality risk remain obscure, given
the less angiographically severe coronary disease and better
left ventricular function among the younger women. Again,
detailed mortality data require ascertainment.
The Yale–New Haven Hospital database, addressing pa-
tients admitted for initial CABG surgery (1999-2001),
showed that women had a 6- to 8-week hospital readmission
rate of 20.5% versus 11% for men. More detailed informa-
tion might identify the reasons for readmission and suggest
interventions likely to curtail these problems. Other recov-
ery comorbid factors for women included an excessive
decline in physical functional level and an increase in de-
pressive symptoms.8
An abstract report from the Northern New England Car-
diovascular Disease Study Group9 based on 26,725 consec-
utive patients undergoing isolated CABG surgery (1993-
2000) showed that greater than 97% of the excess mortality
among women reflected those with diabetes or urgent or
emergency presentations. The conclusion was that tight
blood glucose control during the perioperative period and
excellent medical treatment of acute coronary syndromes,
particularly among women, may be important targets for
process improvement. Does lesser risk stratification to de-
fine and address high risk women during the period of stable
angina among women increase the likelihood of urgent or
emergency presentation? Women have more severe chest
pain and report greater limitation of functional capacity at
presentation for CABG surgery. Is the decision for surgery
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inappropriately delayed, initiating a vicious circle? In this
cohort, hospital mortality rate was 4.1% for women versus
2.4% for men.
What We Must Learn
Detailed review of available databases should enable delin-
eation of the temporal issues and specific characteristics of
the increased perioperative mortality for women. Is this
operative mortality, early perioperative mortality, or mor-
tality during the remainder of the hospital stay? Are there
sex differences in anesthesia, in pain management? Does
preoperative control of coronary risk factors, particularly
diabetes, hypertension, and hyperlipidemia, exert an effect?
Does mortality differ by age or diabetic status, to name a
few factors? An excess of bleeding complications has been
described for women with all interventional procedures.
Does this play a role in mortality? Is there greater reopera-
tion related to bleeding? What is the role of preoperative
anemia?
With hypertrophy of the left ventricle prominent in
women, does intraoperative protection against myocardial
ischemia play a role? Are the symptoms or other manifes-
tations of perioperative heart failure due to diastolic dys-
function misinterpreted as those owing to ventricular sys-
tolic dysfunction and is inappropriate therapy instituted? Is
there comparable aggressive pharmacologic risk reduction
early in the postoperative phase for women as for men? Are
there pathophysiologic differences in coronary plaque and
in coronary vasoactivity and/or endothelial function that
may contribute to the adverse outcome? How can these be
ascertained?
What is the role of precise glucose control, and does it
relate to the preoperative as well as the postoperative phase?
Does angiotensin-converting enzyme inhibitor therapy, as
well as glucose-managing drugs, play a role? Should lipid-
lowering drugs be reinstituted earlier? Is this comparable by
sex? What is the role of aspirin resumption?
These and multiple other probes of the available data
must be designed to ascertain baseline characteristics and to
suggest management strategies that may differ by sex. The
goal is the elimination or lessening of the sex-based excess
morbidity and mortality of CABG surgery, in particular
addressing the excess mortality in younger women com-
pared with their male peers.
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